Author

Anvita Devineni

The University of Texas Southwestern Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Anwesha B Ghosh· 1 shared Carlos M. RoggeroiD· 1 shared Eliot B. BlattiD· 1 shared Ganesh V. RajiD· 1 shared Shihong MaiD· 1 shared Yi YiniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anwesha B Ghosh

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CDK4/6 inhibitors promote PARP1 degradation and act synergistically with PARP inhibitors in non-small cell lung cancer

Carlos M. Roggero, Anwesha B Ghosh, Anvita Devineni, Shihong Ma, Eliot B. Blatt, Ganesh V. Raj, Yi Yin

This study shows CDK4/6 inhibitors promote PARP1 degradation and synergize with PARP inhibitors to kill NSCLC cells by enhancing DNA damage and apoptosis.

Translational Oncology · Dec 10, 2024Peer-reviewedCancer Biology